Cargando…

Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease

Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Hataji, Osamu, Nishii, Yoichi, Ito, Kentaro, Sakaguchi, Tadashi, Saiki, Haruko, Suzuki, Yuta, D'Alessandro-Gabazza, Corina, Fujimoto, Hajime, Kobayashi, Tetsu, Gabazza, Esteban C., Taguchi, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/
https://www.ncbi.nlm.nih.gov/pubmed/29104624
http://dx.doi.org/10.3892/etm.2017.5088
_version_ 1783274056838021120
author Hataji, Osamu
Nishii, Yoichi
Ito, Kentaro
Sakaguchi, Tadashi
Saiki, Haruko
Suzuki, Yuta
D'Alessandro-Gabazza, Corina
Fujimoto, Hajime
Kobayashi, Tetsu
Gabazza, Esteban C.
Taguchi, Osamu
author_facet Hataji, Osamu
Nishii, Yoichi
Ito, Kentaro
Sakaguchi, Tadashi
Saiki, Haruko
Suzuki, Yuta
D'Alessandro-Gabazza, Corina
Fujimoto, Hajime
Kobayashi, Tetsu
Gabazza, Esteban C.
Taguchi, Osamu
author_sort Hataji, Osamu
collection PubMed
description Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combination therapy affects daily physical performance in patients with COPD under a smart watch-based encouragement program. This was a non-blinded clinical trial with no randomization or placebo control. A total of 20 patients with COPD were enrolled in the present study. The patients carried an accelerometer for 4 weeks; they received no therapy during the first 2 weeks but they were treated with combined tiotropium and olodaterol under a smart watch-based encouragement program for the last 2 weeks. The pulmonary function test, COPD assessment test, 6-min walk distance and parameters of physical activity were significantly improved (P<0.05) by combination therapy under smart watch-based coaching compared with values prior to treatment. To the best of our knowledge, the present study for the first time provides evidence that smart watch-based coaching in combination with tiotropium and olodaterol may improve daily physical activity in chronic obstructive pulmonary disease.
format Online
Article
Text
id pubmed-5658686
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-56586862017-11-04 Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease Hataji, Osamu Nishii, Yoichi Ito, Kentaro Sakaguchi, Tadashi Saiki, Haruko Suzuki, Yuta D'Alessandro-Gabazza, Corina Fujimoto, Hajime Kobayashi, Tetsu Gabazza, Esteban C. Taguchi, Osamu Exp Ther Med Articles Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combination therapy affects daily physical performance in patients with COPD under a smart watch-based encouragement program. This was a non-blinded clinical trial with no randomization or placebo control. A total of 20 patients with COPD were enrolled in the present study. The patients carried an accelerometer for 4 weeks; they received no therapy during the first 2 weeks but they were treated with combined tiotropium and olodaterol under a smart watch-based encouragement program for the last 2 weeks. The pulmonary function test, COPD assessment test, 6-min walk distance and parameters of physical activity were significantly improved (P<0.05) by combination therapy under smart watch-based coaching compared with values prior to treatment. To the best of our knowledge, the present study for the first time provides evidence that smart watch-based coaching in combination with tiotropium and olodaterol may improve daily physical activity in chronic obstructive pulmonary disease. D.A. Spandidos 2017-11 2017-09-01 /pmc/articles/PMC5658686/ /pubmed/29104624 http://dx.doi.org/10.3892/etm.2017.5088 Text en Copyright: © Hataji et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Hataji, Osamu
Nishii, Yoichi
Ito, Kentaro
Sakaguchi, Tadashi
Saiki, Haruko
Suzuki, Yuta
D'Alessandro-Gabazza, Corina
Fujimoto, Hajime
Kobayashi, Tetsu
Gabazza, Esteban C.
Taguchi, Osamu
Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
title Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
title_full Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
title_fullStr Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
title_full_unstemmed Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
title_short Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
title_sort smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/
https://www.ncbi.nlm.nih.gov/pubmed/29104624
http://dx.doi.org/10.3892/etm.2017.5088
work_keys_str_mv AT hatajiosamu smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT nishiiyoichi smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT itokentaro smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT sakaguchitadashi smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT saikiharuko smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT suzukiyuta smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT dalessandrogabazzacorina smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT fujimotohajime smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT kobayashitetsu smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT gabazzaestebanc smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease
AT taguchiosamu smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease